Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 29, 2022

SELL
$1.42 - $3.15 $14,261 - $31,635
-10,043 Closed
0 $0
Q1 2022

Apr 29, 2022

SELL
$2.65 - $5.08 $13,329 - $25,552
-5,030 Reduced 33.37%
10,043 $30,000
Q4 2021

Feb 07, 2022

SELL
$4.73 - $7.9 $66,044 - $110,307
-13,963 Reduced 48.09%
15,073 $72,000
Q3 2021

Nov 01, 2021

BUY
$5.16 - $7.98 $149,825 - $231,707
29,036 New
29,036 $220,000

Others Institutions Holding SURF

About Surface Oncology, Inc.


  • Ticker SURF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,034,000
  • Description
  • Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...
More about SURF
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.